News Sentiment

OGI sentiment intelligence

OrganiGram Holdings Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 0.97 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

77/100 classification confidence.

Company focus 63

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

-6.2% over one week, -8.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

OrganiGram (OGI) Investor Presentation Summary

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings 77/100 classification
One-week reaction -6.2% Price reacting lower
Trend fit Trend inactive -8.8% over four weeks
Fair value -36.8% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 39
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 63
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
TradingKey 7
Business Wire 6
AD HOC NEWS 4
Seeking Alpha 3
Moomoo 3
Ad-hoc-news.de 2
Simply Wall Street 2

Event Lens

What the news is about

Classified themes
Earnings 30
Market update 21
Deals and strategy 7
Analyst action 3
Guidance 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 63
Investing.com Direct company coverage

Earnings call transcript: OrganiGram posts Q2 2026 financial misses, stock dips

OrganiGram Holdings Inc. reported Q2 fiscal 2026 earnings with an EPS miss of -2.61% and a significant revenue shortfall of -16.53%, leading to a 4.26% stock decline. The company cited internal operational issues in vapes and infused pre-rolls, along with market growth decelerati

Tone
Negative 19/100
Event
Earnings
Published
12 May 2026 12:40
Source
Investing.com
The Globe and Mail Direct company coverage

Small caps to watch: Pet Valu and Organigram shares sink after earnings, a dividend suspension, and much more

This article examines several Canadian small-cap stocks that recently experienced significant changes following their latest earnings reports. Pet Valu and Organigram saw their shares sink due to missed expectations and decreased revenue, respectively, while Sylogist Ltd. suspend

Tone
Neutral 50/100
Event
Earnings
Published
12 May 2026 11:39
Source
The Globe and Mail
Business Wire Direct company coverage

Organigram Reports Second Quarter Fiscal 2026 Results

Organigram Global Inc. reported its Q2 Fiscal 2026 results, showing a 9% year-over-year decrease in both gross and net revenue, primarily due to underperformance in vapes and challenges in infused pre-roll production. Despite the revenue decline, the company saw record harvest yi

Tone
Neutral 50/100
Event
Earnings
Published
12 May 2026 09:39
Source
Business Wire
Market source Direct company coverage

OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates

OrganiGram (OGI) reported a Q2 loss of $0.01 per share, meeting the Zacks Consensus Estimate, but missed revenue estimates with $43.59 million against an expected $58.38 million. The company's shares have declined by 22% year-to-date, and its Zacks Rank is currently a #3 (Hold),

Tone
Neutral 50/100
Event
Earnings
Published
12 May 2026 09:15
Source
Market source
AD HOC NEWS Direct company coverage

Organigram Holdings stock (CA68620P1018): Earnings report due this week on cannabis leader

Organigram Holdings (OGI) is scheduled to release its second-quarter fiscal 2026 results on May 12, 2026, before market open. The report will cover performance for the period ending March 31, 2026, from Canada's top cannabis company by market share. The company's Nasdaq-listed sh

Tone
Negative 37/100
Event
Earnings
Published
10 May 2026 08:39
Source
AD HOC NEWS